The Supreme Court Roundup ruling in Monsanto v. Durnell did not decide whether glyphosate causes cancer, even though many headlines framed it that way. Instead, the court held that federal pesticide law preempts a state failure-to-warn claim when the Environmental Protection Agency has not required a cancer warning on the product label. That is a significant legal outcome — but it is not the same as a scientific verdict on the herbicide’s safety.

What the Supreme Court Roundup ruling actually decided

At its core, the decision is about labeling authority, not biology. The court found that when the EPA has reviewed a pesticide and not mandated a cancer warning, federal law overrides a state lawsuit claiming the manufacturer failed to warn of that same risk. The ruling resolves who gets to set warning requirements; it does not weigh in on the underlying chemistry of glyphosate, the active ingredient in Roundup.

This is why reading the verdict as “the court says glyphosate is safe” misses the point. The justices answered a question about preemption and regulatory power, leaving the scientific debate exactly where it was.

Why causation means different things in science and law

The ruling highlights a recurring problem: science and law use the same word, causation, while asking very different questions. In epidemiology, causation is usually a population-level inference. Researchers test whether an exposure reliably changes disease risk across groups, relying on replication, statistical association, dose-response evidence, biological plausibility, and efforts to rule out confounding. Even then, conclusions stay probabilistic.

Civil litigation has a different job. A plaintiff generally must show that a specific injury would probably not have occurred without the defendant’s conduct. That standard exists to resolve disputes and assign responsibility, not to establish scientific consensus. A jury weighs one plaintiff’s exposure history, diagnosis, expert testimony, and corporate conduct — so a verdict can clear a legal threshold without settling the broader research. For more context on health and research debates, see our health coverage.

How this plays out across other cases

Glyphosate sits in a zone of genuine disagreement among expert bodies. In 2015, the International Agency for Research on Cancer (IARC) classified it as probably carcinogenic to humans, while the EPA and the European Food Safety Authority have not reached that conclusion under their own frameworks. Similar tensions appear across high-profile litigation:

  • Talc: IARC classified talc as probably carcinogenic in 2024, yet that does not mean every cancer following talc use was caused by it.
  • Social media and youth mental health: isolating platform effects from sleep loss, bullying, genetics, and reverse causation remains difficult, even as lawsuits proceed.
  • Asbestos: here legal and scientific causation often align, since the link to mesothelioma is strong and widely accepted.

The asbestos comparison is instructive: when the science is robust, courtrooms and laboratories tend to agree. The friction appears precisely where the evidence is contested, as with glyphosate and talc — a recurring theme in our science reporting.

Why the distinction matters

Public confusion grows when verdicts, settlements, and regulatory decisions are all read as scientific proof. Large jury awards can make uncertain science look settled, while cautious science can look like corporate evasion. The argument here is that courts and journalists should be explicit about which question is being answered — general causation, specific causation, failure to warn, or legal preemption. A courtroom can assign responsibility without resolving the science, and a regulator can stay cautious without denying harm. Keeping those lanes distinct is the only way to read rulings like Monsanto v. Durnell honestly.

Frequently asked questions

Did the Supreme Court rule that Roundup is safe?

No. The court ruled on whether federal pesticide law preempts state failure-to-warn claims when the EPA has not required a cancer warning. It did not decide whether glyphosate causes cancer.

Why do IARC and the EPA disagree about glyphosate?

They use different frameworks and weigh evidence differently. IARC classified glyphosate as probably carcinogenic in 2015, while the EPA and EFSA have not reached that conclusion under their respective regulatory standards.